April 2019

Editorial Commentary 
Induction chemotherapy for locally advanced thymic epithelial tumors: consideration from the RYTHMIC prospective cohort
Kazuo Nakagawa
Mediastinum  
2019,  
3:
13  
Editorial Commentary 
WT1 peptide-based immunotherapy for refractory thymic epithelial malignancies
Mikito Suzuki, Tomoyuki Hishida, Keisuke Asakura, Hisao Asamura
Mediastinum  
2019,  
3:
12  
Editorial Commentary 
WT1 as an immunotherapy target for thymic epithelial tumors: a novel method to activate anti-tumor immunity
Nobuyuki Takahashi, Chen Zhao, Arun Rajan
Mediastinum  
2019,  
3:
11